RECRUITING

The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to learn if reducing bacterial load on the skin and nostrils with topical antibacterial soap and ointment, respectively, reduces rate of infection in surgical sites on lower leg wounds left open to heal in adults undergoing skin cancer surgery. The main question it aims to answer is: Does Hibiclens antibacterial skin cleanser and mupirocin antibacterial ointment applied to nostrils prior to surgery lower the number of times participants develop an infection in their open wound on the lower leg? Researchers will compare the treatment group to the standard of care, which involves no treatment prior to surgery, to see if topical antibiotics applied prior to surgery affect infection rates between the two groups. Participants randomized to the treatment group will: Shower with Hibiclens once daily for 5 days prior to the day of surgery and apply mupirocin to the nostrils twice daily for 5 days prior to the day of surgery. They will then send pictures of their surgical site to monitor for signs of infection at 2-week and 4-week post-operation. Participants randomized to the control group (standard of care) will: NOT apply the topical antibacterials prior to the day of surgery. They will then send pictures of their surgical site to monitor for signs of infection at 2-week intervals for 1 month after surgery.

Official Title

The Effect of Pre-Operative Bacterial Decolonization on Post-Operative Infection Rate for Lower Extremity Wounds Healing by Second Intention

Quick Facts

Study Start:2023-03-13
Study Completion:2030-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07142408

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age at least 18 years old
  2. * Scheduled to undergo surgical treatment for skin cancer on the lower extremities and have no other surgeries scheduled in the coming weeks after the procedure
  3. * Will have a surgical wound that will be left open to heal by secondary intention
  1. * Age under 18 years old
  2. * Have a known allergy to chlorhexidine or mupirocin
  3. * Have a history of Staphylococcus aureus infection
  4. * Have a history of heart valve or joint replacement surgery requiring pre-operative antibiotics

Contacts and Locations

Study Contact

Naomi Lawrence, MD
CONTACT
(856) 596-3040
lawrence-naomi@cooperhealth.edu
Faria Nusrat, BS
CONTACT
(856) 596-3040
nusrat-faria@cooperhealth.edu

Study Locations (Sites)

The Center for Dermatologic Surgery at Cooper University Health Care
Marlton, New Jersey, 08053
United States

Collaborators and Investigators

Sponsor: The Cooper Health System

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-03-13
Study Completion Date2030-12

Study Record Updates

Study Start Date2023-03-13
Study Completion Date2030-12

Terms related to this study

Keywords Provided by Researchers

  • Lower Extremity Wound
  • Skin Cancer Surgery
  • Infection Rate
  • Prophylactic Topical Antibiotics
  • Chlorhexidine
  • Mupirocin
  • Wound Healing
  • Secondary Intention
  • Infection Prevention

Additional Relevant MeSH Terms

  • Surgical Wound Infection